<DOC>
	<DOCNO>NCT00302653</DOCNO>
	<brief_summary>The purpose study determine whether rasburicase effective safety correct hyperuricemia .</brief_summary>
	<brief_title>Rasburicase Tumor Lysis Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Tumor Lysis Syndrome</mesh_term>
	<mesh_term>Rasburicase</mesh_term>
	<criteria>List inclusion Criteria : Acute hyperuricemia patient ( uric acid &gt; 8.0 mg/dl ) before/during chemotherapy hematologic malignancy . List exclusion Criteria : Hypersensitivity uricases excipients . Known history hemolytic anemia ( G6PD deficiency ) . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>